CVE-2023-31167
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
- Published
- Last modified
- Where the record stands: published, rejected by its publisher, or superseded by another id.What do these mean? →
- published
- Whether CISA lists it in its Known Exploited Vulnerabilities catalog: proof that attackers are using it.What do these mean? →
- Not listed in CISA KEV
- Fix
- Fixed in 1.0.49152.778
- Whether working attack code is public (Exploit-DB, Metasploit, Nuclei or GitHub). Public code makes attacks easier.What do these mean? →
- None on Exploit-DB, Metasploit or GitHub
CISA's decision points: whether it is exploited, whether attacks can be automated, and how much control an attacker gets. Assessed (SSVC 2.0.3).What do these mean? →
- Exploitation: none
- Automatable: no
- Technical impact: partial
Summary
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows Relative Path Traversal. SEL acSELerator Bay Screen Builder software is distributed by SEL-5033 SEL acSELerator RTAC, SEL-5030 Quickset, and SEL Compass. CVE-2023-31167 and was patched in the acSELerator Bay Screen Builder release available on 20230602. Please contact SEL for additional details. This issue affects SEL-5036 acSELerator Bay Screen Builder Software: before 1.0.49152.778.
Timeline
- CVE published
- CISA SSVC assessment
Exploitation: none · Automatable: no · Technical impact: partial
- Record last updated
Affected versions
- Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software
fixed in 1.0.49152.778